Insights

Regional Expansion Opportunities NewBridge Pharmaceuticals has established a strong presence in the Middle East and Africa, focusing on addressing unmet medical needs in oncology, immunology, neuroscience, gastrointestinal, and rare diseases. Their strategic regional focus and access to diverse markets present significant sales opportunities for pharmaceutical and biotech companies seeking multi-country distribution channels and market entry support in these regions.

Collaborative Distribution Channels The company's history of forming exclusive licensing and distribution agreements with international pharmaceutical firms, such as Pharming Group and BioCryst Pharmaceuticals, highlights their capability to serve as a trusted regional partner. This positions them well for sales collaborations involving innovative biologics and specialty medicines targeted at specialized markets in the MENA region.

Access to Growing Markets With a proven track record of supporting commercialization efforts and approved products in rapidly growing economies, NewBridge offers an excellent platform for companies looking to expand their footprint in emerging healthcare markets, especially given the complex regulatory landscape in the Middle East and Africa.

Financial and Investment Support Backed by substantial funding and institutional investors, including a $240 million financing, NewBridge demonstrates strong financial stability and growth potential. Partnerships can leverage this resource backing to accelerate regional sales initiatives, product launches, and market penetration.

Digital and Regulatory Expertise Utilizing a broad tech stack and compliance-focused practices, NewBridge’s operational strength in regulatory affairs, medical affairs, and digital marketing makes it an attractive partner for companies seeking to navigate complex healthcare regulations and optimize product visibility in the MENA region.

Similar companies to NewBridge Pharmaceuticals

NewBridge Pharmaceuticals Tech Stack

NewBridge Pharmaceuticals uses 8 technology products and services including Unpkg, Cloudflare, MySQL, and more. Explore NewBridge Pharmaceuticals's tech stack below.

  • Unpkg
    Content Delivery Network
  • Cloudflare
    Content Management System
  • MySQL
    Database
  • Twemoji
    Font Scripts
  • Slick
    Javascript Libraries
  • LinkedIn
    Online Community Software
  • Yoast SEO
    Search Engines
  • Google Tag Manager
    Tag Management

Media & News

NewBridge Pharmaceuticals's Email Address Formats

NewBridge Pharmaceuticals uses at least 1 format(s):
NewBridge Pharmaceuticals Email FormatsExamplePercentage
First.Last@nbpharma.comJohn.Doe@nbpharma.com
86%
First@nbpharma.comJohn@nbpharma.com
8%
F-Last@nbpharma.comJ-Doe@nbpharma.com
3%
First.Middle@nbpharma.comJohn.Michael@nbpharma.com
3%

Frequently Asked Questions

What is NewBridge Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact NewBridge Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is NewBridge Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
NewBridge Pharmaceuticals's official website is nbpharma.com and has social profiles on LinkedInCrunchbase.

What is NewBridge Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign icon
NewBridge Pharmaceuticals's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does NewBridge Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of December 2025, NewBridge Pharmaceuticals has approximately 259 employees across 5 continents, including AsiaAfricaNorth America. Key team members include Chief Corporate Development Officer: M. A.Vice President & General Manager: T. S.Vp & Regional Head Of Business Operations - Middle East Africa: H. E. S.. Explore NewBridge Pharmaceuticals's employee directory with LeadIQ.

What industry does NewBridge Pharmaceuticals belong to?

Minus sign iconPlus sign icon
NewBridge Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does NewBridge Pharmaceuticals use?

Minus sign iconPlus sign icon
NewBridge Pharmaceuticals's tech stack includes UnpkgCloudflareMySQLTwemojiSlickLinkedInYoast SEOGoogle Tag Manager.

What is NewBridge Pharmaceuticals's email format?

Minus sign iconPlus sign icon
NewBridge Pharmaceuticals's email format typically follows the pattern of First.Last@nbpharma.com. Find more NewBridge Pharmaceuticals email formats with LeadIQ.

How much funding has NewBridge Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of December 2025, NewBridge Pharmaceuticals has raised $48M in funding. The last funding round occurred on May 29, 2013 for $48M.

When was NewBridge Pharmaceuticals founded?

Minus sign iconPlus sign icon
NewBridge Pharmaceuticals was founded in 2010.

NewBridge Pharmaceuticals

Pharmaceutical ManufacturingDubai, United Arab Emirates201-500 Employees

NewBridge Pharmaceuticals is a regional specialty company established to bridge the access gap and partner with pharma & biotech companies to in-license and commercialize FDA or EMA/European approved innovative pharmaceutics, biologics, & other healthcare solutions in the Middle East and Africa region. 

The areas of Oncology, Immunology, Neuroscience, Gastrointestinal & Rare Disease are NBP’s current strategic focus. The existing product portfolio was built to address unmet medical needs in the region & enabled the company not just to gain substantial presence, but also to help patients gain access to these much-needed innovations.

NewBridge is driven by highly experienced leadership in the biopharmaceutical industry regionally & globally, as well as talented motivated teams with a proven track record of regional achievements, which collectively has allowed NewBridge to establish itself as a strategic & successful pharmaceutical partner  of choice in the MENA Region.

NewBridge offers flexible partnership opportunities & best practices in the areas of commercial, regulatory, and medical affairs striving for quality performance & high standards of compliance that pharmaceutical companies look for in a partner to serve as an extension of their practices & values in local markets.

NewBridge is well backed by strong institutional & corporate investors who provide us with the extensive life science network & diverse investment expertise needed to achieve our vision & build  a platform of successful alliances in the region, and create value in an innovative business approach.

This integrated strategy of regional expertise & strong global business network position NewBridge uniquely as an institutional one-stop-solution for our partners in its offering & as a preferred partner-of-choice for the biopharmaceutical & other healthcare companies seeking multi-country access in Middle East and Africa   with its growing economies, yet complex regulations & access hurdles.

Section iconCompany Overview

Phone number
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2010
Employees
201-500

Section iconFunding & Financials

  • $48M

    NewBridge Pharmaceuticals has raised a total of $48M of funding over 2 rounds. Their latest funding round was raised on May 29, 2013 in the amount of $48M.

  • $10M$25M

    NewBridge Pharmaceuticals's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $48M

    NewBridge Pharmaceuticals has raised a total of $48M of funding over 2 rounds. Their latest funding round was raised on May 29, 2013 in the amount of $48M.

  • $10M$25M

    NewBridge Pharmaceuticals's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.